Jackson Square Capital’s Acadia Healthcare ACHC Stock Holding History

Jackson Square Capital’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-80	Closed	-$3K	–	310
2019 Q4	$3K	Buy	+80	New	+$2.51K	﹤0.01%	350

Other funds holding ACHC

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PCP

P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

ABI

Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jackson Square Capital's ACHC Position: Q1 2020 in Review

Jackson Square Capital sold out of Acadia Healthcare (ACHC) in Q1 2020, closing a stake of 80 shares — an estimated $3K sold.

Jackson Square Capital first reported a position in ACHC in Q4 2019 and held it in 1 quarter. The position peaked at $3K in Q4 2019. 218 funds tracked by Wall St. Rank hold ACHC as of Q1 2020.

Jackson Square Capital reported no remaining Acadia Healthcare position as of Q1 2020 after selling out during the quarter.
Jackson Square Capital sold 80 Acadia Healthcare shares in Q1 2020, an estimated $3K.
Jackson Square Capital first reported a position in Acadia Healthcare in Q4 2019 and held it in 1 quarter.
Jackson Square Capital's Acadia Healthcare position peaked at $3K in Q4 2019.
218 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2020.

Based on Jackson Square Capital's 13F filing for Q1 2020, filed 15 May 2020.